GLP-1 weight-loss drugs will still be cheap with Medicare, but there's a catch [USA TODAY]
CVS Health Corporation (CVS)
Last cvs health corporation earnings: 2/12 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.cvshealth.com
Company Research
Source: USA TODAY
Full Summary Medicare postponed the voluntary BALANCE program for GLP-1 obesity drugs and will instead run a temporary bridge program from July?1?2026 through December?31?2027, letting seniors obtain Wegovy, Zepbound and similar treatments for a $50 monthly copay under Trump-era price agreements. Insurers such as CVS Health and UnitedHealth declined to join BALANCE, while Medicaid participation remains open until July?31?2026. Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound That doesn't mean Medicare enrollees will go without these popular weight-loss drugs . Medicare will offer GLP-1 weight-loss drugs through a bridge program from July 1, 2026, through December 31, 2027, a Centers for Medicare & Medicaid Services (CMS) spokesperson said. The bridge program will allow enrollees in Medicare, the federal health program for adults 65 a
Show less
Read more
Impact Snapshot
Event Time:
CVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVS alerts
High impacting CVS Health Corporation news events
Weekly update
A roundup of the hottest topics
CVS
News
- Samsung Epis Holdings Reports First Quarter 2026 Financial Results [Yahoo! Finance]Yahoo! Finance
- Is CVS Health the Ultimate Value Stock to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- Is CVS Health the Ultimate Value Stock to Buy Right Now? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Medigap premiums leap, and consumers have few alternatives [CBS News]CBS News
- Tennessee lawmakers advance pharmacy bill as CVS threatens lawsuit [USA TODAY]USA TODAY
CVS
Earnings
- 2/10/26 - Beat
CVS
Sec Filings
- 4/3/26 - Form ARS
- 4/3/26 - Form DEF
- 4/3/26 - Form DEFA14A
- CVS's page on the SEC website